BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12063175)

  • 21. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels.
    Rivera P; Ocaranza MP; Lavandero S; Jalil JE
    Hypertension; 2007 Oct; 50(4):792-8. PubMed ID: 17785632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
    Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
    Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm.
    Wickman G; Lan C; Vollrath B
    Circ Res; 2003 Apr; 92(7):809-16. PubMed ID: 12637369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts.
    Tsuji T; Ishizaki T; Okamoto M; Higashida C; Kimura K; Furuyashiki T; Arakawa Y; Birge RB; Nakamoto T; Hirai H; Narumiya S
    J Cell Biol; 2002 May; 157(5):819-30. PubMed ID: 12021256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho signaling pathway targeted to promote spinal cord repair.
    Dergham P; Ellezam B; Essagian C; Avedissian H; Lubell WD; McKerracher L
    J Neurosci; 2002 Aug; 22(15):6570-7. PubMed ID: 12151536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase.
    Park HJ; Galper JB
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11525-30. PubMed ID: 10500210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
    Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
    J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes.
    Methe H; Kim JO; Kofler S; Nabauer M; Weis M
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1439-45. PubMed ID: 15860745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
    Krijnen PA; Sipkens JA; Molling JW; Rauwerda JA; Stehouwer CD; Muller A; Paulus WJ; van Nieuw Amerongen GP; Hack CE; Verhoeven AJ; van Hinsbergh VW; Niessen HW
    J Mol Cell Cardiol; 2010 Nov; 49(5):781-90. PubMed ID: 20691698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor.
    Ikenoya M; Hidaka H; Hosoya T; Suzuki M; Yamamoto N; Sasaki Y
    J Neurochem; 2002 Apr; 81(1):9-16. PubMed ID: 12067241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase.
    Wahl S; Barth H; Ciossek T; Aktories K; Mueller BK
    J Cell Biol; 2000 Apr; 149(2):263-70. PubMed ID: 10769020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].
    Nakayama M; Amano M; Kawabata S; Kaibuchi K; Takefuji M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():202-6. PubMed ID: 15171369
    [No Abstract]   [Full Text] [Related]  

  • 37. Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.
    Essig M; Vrtovsnik F; Nguyen G; Sraer JD; Friedlander G
    J Am Soc Nephrol; 1998 Aug; 9(8):1377-88. PubMed ID: 9697659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purkinje cell survival in organotypic cultures: implication of Rho and its downstream effector ROCK.
    Julien S; Schnichels S; Teng H; Tassew N; Henke-Fahle S; Mueller BK; Monnier PP
    J Neurosci Res; 2008 Feb; 86(3):531-6. PubMed ID: 17893923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.